Stockscreener 앱 받기
0.831
2.12%
-0.017
시간 외 거래:
.83
-0.001
-0.12%
전일 마감가:
$0.848
열려 있는:
$0.8396
하루 거래량:
211.18K
Relative Volume:
0.87
시가총액:
$35.29M
수익:
$98.92M
순이익/손실:
$-1.24M
주가수익비율:
-13.85
EPS:
-0.06
순현금흐름:
$2.64M
1주 성능:
-3.90%
1개월 성능:
-15.57%
6개월 성능:
-59.31%
1년 성능:
-50.30%
1일 변동 폭
$0.80
$0.842
1주일 범위
$0.7801
$0.8887
52주 변동 폭
$0.7801
$5.15
락웰 메디컬 Stock (RMTI) Company Profile
명칭
Rockwell Medical Inc
전화
(800) 449-3353
주소
30142 WIXOM ROAD, WIXOM, NJ
RMTI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RMTI
Rockwell Medical Inc
|
0.831 | 35.29M | 98.92M | -1.24M | 2.64M | -0.06 |
|
RGC
Regencell Bioscience Holdings Ltd
|
14.60 | 303.95B | 0 | -5.87M | -767.30K | -0.45 |
|
ZTS
Zoetis Inc
|
159.19 | 74.39B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.36 | 48.97B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.37 | 47.39B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.65 | 20.17B | 16.54B | -1.64B | 749.00M | -1.45 |
락웰 메디컬 Stock (RMTI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-14 | 개시 | Rodman & Renshaw | Buy |
| 2019-06-24 | 개시 | Piper Jaffray | Overweight |
| 2019-05-13 | 개시 | H.C. Wainwright | Buy |
| 2016-11-08 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2016-03-01 | 다운그레이드 | Stifel | Buy → Hold |
| 2015-08-13 | 개시 | Morgan Stanley | Underweight |
| 2015-01-27 | 재확인 | Oppenheimer | Outperform |
| 2015-01-07 | 개시 | Oppenheimer | Outperform |
| 2014-08-14 | 개시 | FBR Capital | Underperform |
| 2013-12-19 | 개시 | Chardan Capital Markets | Buy |
| 2013-11-06 | 재확인 | Summer Street Research | Buy |
| 2013-09-05 | 재확인 | Summer Street Research | Buy |
| 2013-08-02 | 재확인 | Summer Street Research | Buy |
| 2012-04-11 | 개시 | Summer Street Research | Buy |
| 2012-03-12 | 개시 | Stifel Nicolaus | Buy |
| 2012-01-03 | 개시 | Canaccord Genuity | Buy |
| 2009-12-10 | 개시 | JMP Securities | Mkt Outperform |
| 2009-10-12 | 개시 | Wedbush Morgan | Outperform |
모두보기
락웰 메디컬 주식(RMTI)의 최신 뉴스
Intravenous Iron Drugs Market to Reach USD 6.63 Bn by 2032 - newstrail.com
Rockwell Medical (NASDAQ:RMTI) Raised to Hold at Wall Street Zen - Defense World
Millennium Management LLC Cuts Position in Rockwell Medical, Inc. (NASDAQ:RMTI) - Defense World
RMTIRockwell Medical Announces First Quarter 2025 Results - Revista ADVFN
Dialysis Equipment Market to Reach $191.24 Bn by 2032 - newstrail.com
Key Market Driver in intravenous iron drugs Industry 2025: RisinNORTHEAST - NORTHEAST - NEWS CHANNEL NEBRASKA
Iron Deficiency Anemia Market Accelerates with Health Programs - openPR.com
Rockwell Medical (NASDAQ:RMTI) Downgraded to “Sell” Rating by Wall Street Zen - Defense World
Dialysate Market Insights: Growing at 6.04% CAGR to USD 9.8 Billion by 2031 - openPR.com
HC Wainwright Issues Pessimistic Estimate for RMTI Earnings - Defense World
Acidic Bicarbonate Concentrates Market Set for Strong - GlobeNewswire
Rockwell Med Holds 2025 Annual Stockholders Meeting - TipRanks
Dimensional Fund Advisors LP Invests $146,000 in Rockwell Medical, Inc. (NASDAQ:RMTI) - Defense World
Raymond James Financial Inc. Invests $28,000 in Rockwell Medical, Inc. (NASDAQ:RMTI) - Defense World
Rockwell Medical reiterates $65M–$70M 2025 sales guidance while pursuing new customers and product expansion - MSN
Rockwell Medical, Inc. (NASDAQ:RMTI) Q1 2025 Earnings Call Transcript - Insider Monkey
Rockwell Medical Inc (RMTI) Q1 2025 Earnings Call Highlights: Navigating Challenges and ... - Yahoo Finance
Rockwell Medical Inc (RMTI) Q1 2025 Earnings Call Highlights: Na - GuruFocus
Rockwell Medical Reports Q1 2025 Financial Results - TipRanks
Rockwell Medical’s Earnings Call: Navigating Transition - TipRanks
Rockwell Medical (RMTI) Q1 Revenue Exceeds Expectations Despite Sales Dip - GuruFocus
Rockwell Medical: Q1 Earnings Snapshot - MySA
Rockwell Medical Q1 2025 Earnings Call Transcript - MarketBeat
Transcript : Rockwell Medical, Inc., Q1 2025 Earnings Call, May 12, 2025 - marketscreener.com
Rockwell Medical Inc Q1 2025 Earnings: EPS of -$0.05 Meets Estimates, Revenue of $18.9M Surpasses Expectations - GuruFocus
Earnings call transcript: Rockwell Medical Q1 2025 beats EPS forecast, stock jumps By Investing.com - Investing.com South Africa
Earnings call transcript: Rockwell Medical Q1 2025 beats EPS forecast, stock jumps - Investing.com Nigeria
Rockwell Medical Announces First Quarter 2025 Results - BioSpace
Rockwell Medical Announces First Quarter 2025 Results | RMTI Stock News - GuruFocus
Rockwell Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Rockwell Medical earnings beat by $0.03, revenue fell short of estimates - Investing.com Canada
Rockwell Medical (RMTI) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Rockwell Medical, Inc. Confirms Earnings Guidance for the for Year 2025 - marketscreener.com
ROCKWELL MEDICAL, INC. SEC 10-Q Report - TradingView
Rockwell Med Updates Corporate Presentation May 2025 - TipRanks
Hemodialysis Equipment Market Is Booming So Rapidly with Fresenius Medical Care, Baxter International - newstrail.com
Rockwell Medical (RMTI) Expected to Announce Quarterly Earnings on Monday - Defense World
Rockwell Medical (RMTI) Set to Release Q1 Earnings - GuruFocus
Haemonetics (HAE) Q4 Earnings and Revenues Surpass Estimates - Yahoo Finance
Smart Dialysis System Market to Accelerate Growth with Outset Medical, Medtronic, Rockwell Medical - newstrail.com
Geode Capital Management LLC Purchases 13,122 Shares of Rockwell Medical, Inc. (NASDAQ:RMTI) - Defense World
Renaissance Technologies LLC Has $902,000 Stock Holdings in Rockwell Medical, Inc. (NASDAQ:RMTI) - Defense World
LPL Financial LLC Has $112,000 Stock Holdings in Rockwell Medical, Inc. (NASDAQ:RMTI) - Defense World
Rockwell Medical, Inc. (NASDAQ:RMTI) Stake Increased by XTX Topco Ltd - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Rockwell Medical Investment Trust buys shares worth $94,017 By Investing.com - Investing.com Australia
락웰 메디컬 (RMTI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
락웰 메디컬 주식 (RMTI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Irrevocable Larson Family Inve | 10% Owner |
Apr 11 '25 |
Buy |
1.08 |
30,500 |
32,982 |
3,557,500 |
| Strobeck Mark | President and CEO |
Apr 01 '25 |
Sale |
1.08 |
6,926 |
7,480 |
124,678 |
| Neri Jesse | SVP, FINANCE AND CFO |
Apr 01 '25 |
Sale |
1.10 |
886 |
975 |
30,000 |
| Chole Timothy | SVP, Chief Commercial Officer |
Apr 01 '25 |
Sale |
1.08 |
2,868 |
3,097 |
46,035 |
1.09%
0.60%
자본화:
|
볼륨(24시간):